Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk/Experiment 1/Signature 2
From BugSigDB
< Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk | Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk/Experiment 1
Reviewed Marked as Reviewed by Fatima on 2022/07/3
Source: Table 3
Description: Linear discriminant analysis (LDA) effect size (LEfSe) in samples collected after treatment (week 6)
Abundance in Group 1: decreased abundance in Aspirin
| NCBI | Quality Control | Links |
|---|---|---|
| Veillonella | ||
| Clostridium sp. DL-VIII |
Revision editor(s): Jeshudy, Peace Sandy
